

A recently described three-dimensional structure of the ribosome provides a sense of remarkable diversity of RNA-protein complexes. We have designed a new class of scaffold for artificial receptors, in which a short peptide and RNA with a randomized nucleotide region form a stable and specific complex. The randomized nucleotide region was placed next to the HIV-1 Rev response element to enable the formation of "ribonucleopeptide" pools in the presence of the Rev peptide. In vitro selection of RNA oligonucleotides from the randomized pool afforded a ribonucleopeptide receptor specific for ATP. The ATP-binding ribonucleopeptide did not share the known consensus nucleotide sequence for ATP aptamers and completely lost its ATP-binding ability in the absence of the Rev peptide. The ATP-binding activity of the ribonucleopeptide was increased by a substitution of the N-terminal amino acid of the Rev peptide. These results demonstrate directly that the peptide is incorporated in the functional structure of RNA and suggest that amino acids outside the RNA-binding region of the peptide modulate the ATP-binding of ribonucleopeptide. Our approach would provide an alternative strategy for the design of "tailor-made" ribonucleopeptide receptors and enzymes.
| Engineering uncontrolled terms | Artificial receptor |
|---|---|
| Engineering controlled terms: | EnzymesProteinsRNA |
| Engineering main heading: | Adenosinetriphosphate |
| EMTREE drug terms: | atp binding receptorpeptidereceptorRev proteinribonucleopeptideRNAunclassified drug |
| EMTREE medical terms: | articlebinding affinitycomplex formationconcentration (parameters)Human immunodeficiency virus 1nonhumanprotein analysisprotein RNA bindingribosome |
| MeSH: | Adenosine TriphosphateAmino Acid SequenceBase SequenceGene Products, revMolecular Sequence DataPeptide FragmentsReceptors, Purinergic P2Response ElementsRibonucleoproteinsRNA |
RNA, 63231-63-0; Rev protein, 111804-97-8, 127004-89-1;
Adenosine Triphosphate, 56-65-5; Gene Products, rev; Peptide Fragments; RNA, 63231-63-0; Receptors, Purinergic P2; Ribonucleoproteins
Morii, T.; Institute of Advanced Energy, Kyoto University, Japan Sci./Technology Corporation, Japan;
© Copyright 2011 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.